Skip to main content

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • A report by leading doctors state that the mediterranean diet is 'as effective as statins' in reducing heart attack risk. Risk for heart disease should be lowered through a healthy diet and plenty of exercise than automatically relying on drugs to fix the problem said the paper which is published on September 7. The paper is published in Prescriber.

  • Researchers developed A 'gene signature' that can be used to predict the onset of Alzheimer's years in advance. Such a molecular profile could be useful for distinguishing people at an early risk of age-related diseases, and could improve upon the use of chronological age and complement traditional indicators of disease, such as blood pressure. The study is published in Genome Biology.

  • Sensory Hair Cells in Your Inner Ear Helps You Keep Your Balance While Jogging. The reason for the difference lies in the vestibular organ (VO) located in the inner ear, which controls balance and posture, researchers have reported. The VO senses ongoing self-motion and ensures that, while running, the jogger unconsciously compensates for the accompanying changes in the orientation of the head. The results were reported in the online journal Nature Communications.

  • Tyrosine kinase 2 (Tyk2) is an enzyme involved in intracellular signalling and has an important role in activating the immune system. But enzymatically active Tyk2 can also promote excessive immune reactions and growth of certain cancer types.

    [adsense:336x280:8701650588]

  • High salt in soil threatens to reduce the growth and yield of crops. In a breakthrough discovery, researchers have now identified a protein family that may help plants grow under slat stress. The study was published in Cell.

  • The Indian Patent Office has rejected American drug maker Pfizer's patents for its rheumatoid arthritis drug tofacitinib in India.

    “After having considered the submissions submitted by the applicant (Pfizer) in the hearing, the written submission and amended claims filed as well as in view of the discussions and findings by me, it is hereby ordered that the invention disclosed and claimed in the instant application is not considered as an invention under the provisions of the Act”, said Bharat N S, assistant controller of patents & designs, Mumbai.

Subscribe to Pharma News